Analysis of Aster DM Healthcare Ltd. – Q2 FY26 Financial Performance

Key Highlights: Consolidated Net Profit: ₹110 crore (a 13.6% YoY increase) Consolidated Revenue: ₹1,197 crore (a 10.2% YoY increase) EBITDA: ₹250.1 crore (a 14.0% YoY increase) Operating Margin: 20.9% (a 70 bps YoY expansion) Detailed Financial Analysis Aster DM Healthcare Ltd. has announced a steady financial performance for the second quarter of the fiscal year 2026 (Q2 FY26), demonstrating consistent growth and an improvement in operational efficiency. 1. Profitability Growth (Bottom Line) The company reported a consolidated net profit of ₹110 crore for the quarter ended September 30, 2025. This marks a significant 13.6% year-on-year (YoY) increase compared to the ₹96.8 crore posted in the corresponding period of the previous fiscal year (Q2 FY25). This growth in net profit indicates effective cost management and a stronger bottom-line performance. 2. Revenue Growth (Top Line) Consolidated revenue from operations saw robust growth, rising by 10.2% YoY to ₹1,197 crore for the quarter, up from ₹1,086 crore in Q2 FY25. This steady top-line expansion reflects sustained demand for the company's healthcare services. 3. Operational Efficiency and Margin Expansion A key positive indicator for the quarter was the strong growth in operational earnings. Earnings before interest, tax, depreciation, and amortisation (EBITDA) grew by 14.0% YoY to ₹250.1 crore, compared to ₹219.2 crore in the prior-year period. Crucially, the rate of EBITDA growth (14.0%) outpaced revenue growth (10.2%), signaling enhanced operational efficiency. This led to a healthy 70 basis point (bps) expansion in the company's operating margin, which improved from 20.2% in Q2 FY25 to 20.9% in Q2 FY26. Summary: In summary, Aster DM Healthcare's Q2 FY26 results reflect a solid all-around performance. The company has successfully translated its revenue growth into even stronger operational and net profit growth, supported by a clear improvement in its operating margins.